Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

SYMPTOMATIC AND ASYMPTOMATIC HYPOGLYCEMIA POST THREE DIFFERENT BARIATRIC PROCEDURES: A COMMON AND SEVERE COMPLICATION.

Lazar LO, Sapojnikov S, Pines G, Mavor E, Ostrovsky V, Schiller T, Knobler H, Zornitzki T.

Endocr Pract. 2019 Aug 14. doi: 10.4158/EP-2019-0185. [Epub ahead of print]

PMID:
31412234
2.

A Potentially Malignant Giant Esophageal Paraganglioma.

Arbel Rubinstein T, Kouniavsky G, Kanengisser Pines B, Idelevich E, Lazar LO, Elami A, Bar I, Pines G.

Ann Thorac Surg. 2019 Dec;108(6):e349-e351. doi: 10.1016/j.athoracsur.2019.03.106. Epub 2019 May 8.

PMID:
31077658
3.

Metabolic Syndrome is a Risk Factor for Post-Operative Adhesions: Need for Novel Treatment Strategies.

Pilpel Y, Pines G, Birkenfeld A, Bornstein SR, Miller R.

Horm Metab Res. 2019 Jan;51(1):35-41. doi: 10.1055/a-0798-3931. Epub 2018 Nov 29. Review.

PMID:
30497091
4.

Genomic Deoxyxylulose Phosphate Reductoisomerase (DXR) Mutations Conferring Resistance to the Antimalarial Drug Fosmidomycin in E. coli.

Pines G, Oh EJ, Bassalo MC, Choudhury A, Garst AD, Fankhauser RG, Eckert CA, Gill RT.

ACS Synth Biol. 2018 Dec 21;7(12):2824-2832. doi: 10.1021/acssynbio.8b00219. Epub 2018 Dec 7.

5.

Dynamic Management of Codon Compression for Saturation Mutagenesis.

Pines G, Gill RT.

Methods Mol Biol. 2018;1772:171-189. doi: 10.1007/978-1-4939-7795-6_9.

PMID:
29754228
6.

SILAC identifies LAD1 as a filamin-binding regulator of actin dynamics in response to EGF and a marker of aggressive breast tumors.

Roth L, Srivastava S, Lindzen M, Sas-Chen A, Sheffer M, Lauriola M, Enuka Y, Noronha A, Mancini M, Lavi S, Tarcic G, Pines G, Nevo N, Heyman O, Ziv T, Rueda OM, Gnocchi D, Pikarsky E, Admon A, Caldas C, Yarden Y.

Sci Signal. 2018 Jan 30;11(515). pii: eaan0949. doi: 10.1126/scisignal.aan0949.

PMID:
29382783
7.

Anastomotic Stricture Rates Following Roux-en-Y Gastric Bypass for Morbid Obesity: A Comparison Between Linear and Circular-Stapled Anastomosis.

Khalayleh H, Pines G, Imam A, Sapojnikov S, Buyeviz V, Mavor E.

J Laparoendosc Adv Surg Tech A. 2018 Jun;28(6):631-636. doi: 10.1089/lap.2017.0619. Epub 2017 Dec 13.

PMID:
29237132
8.

Refactoring the Genetic Code for Increased Evolvability.

Pines G, Winkler JD, Pines A, Gill RT.

mBio. 2017 Nov 14;8(6). pii: e01654-17. doi: 10.1128/mBio.01654-17.

9.

Modified Endoscopic Vacuum Therapy for Nonhealing Esophageal Anastomotic Leak: Technique Description and Review of Literature.

Pines G, Bar I, Elami A, Sapojnikov S, Hikri O, Ton D, Mosenkis B, Melzer E.

J Laparoendosc Adv Surg Tech A. 2018 Jan;28(1):33-40. doi: 10.1089/lap.2017.0318. Epub 2017 Oct 11. Review.

PMID:
29019713
10.

Quantitative Tracking of Combinatorially Engineered Populations with Multiplexed Binary Assemblies.

Zeitoun RI, Pines G, Grau WC, Gill RT.

ACS Synth Biol. 2017 Apr 21;6(4):619-627. doi: 10.1021/acssynbio.6b00376. Epub 2017 Jan 24.

PMID:
28103008
11.

Genome-wide mapping of mutations at single-nucleotide resolution for protein, metabolic and genome engineering.

Garst AD, Bassalo MC, Pines G, Lynch SA, Halweg-Edwards AL, Liu R, Liang L, Wang Z, Zeitoun R, Alexander WG, Gill RT.

Nat Biotechnol. 2017 Jan;35(1):48-55. doi: 10.1038/nbt.3718. Epub 2016 Dec 12.

PMID:
27941803
12.

Interfering with the Dimerization of the ErbB Receptors by Transmembrane Domain-Derived Peptides Inhibits Tumorigenic Growth in Vitro and in Vivo.

Bublil EM, Cohen T, Arnusch CJ, Peleg A, Pines G, Lavi S, Yarden Y, Shai Y.

Biochemistry. 2016 Oct 4;55(39):5520-5530. Epub 2016 Sep 19.

PMID:
27575020
13.

The Resistome: A Comprehensive Database of Escherichia coli Resistance Phenotypes.

Winkler JD, Halweg-Edwards AL, Erickson KE, Choudhury A, Pines G, Gill RT.

ACS Synth Biol. 2016 Dec 16;5(12):1566-1577. Epub 2016 Aug 2.

PMID:
27438180
14.

A Web Interface for Codon Compression.

Halweg-Edwards AL, Pines G, Winkler JD, Pines A, Gill RT.

ACS Synth Biol. 2016 Sep 16;5(9):1021-3. doi: 10.1021/acssynbio.6b00026. Epub 2016 May 19.

PMID:
27169595
15.

Bacterial Recombineering: Genome Engineering via Phage-Based Homologous Recombination.

Pines G, Freed EF, Winkler JD, Gill RT.

ACS Synth Biol. 2015 Nov 20;4(11):1176-85. doi: 10.1021/acssynbio.5b00009. Epub 2015 Apr 27. Review.

PMID:
25856528
16.

Multiplexed tracking of combinatorial genomic mutations in engineered cell populations.

Zeitoun RI, Garst AD, Degen GD, Pines G, Mansell TJ, Glebes TY, Boyle NR, Gill RT.

Nat Biotechnol. 2015 Jun;33(6):631-7. doi: 10.1038/nbt.3177. Epub 2015 Mar 23.

PMID:
25798935
17.

Evolutionary Genomics.

Itan Y, Gerbault P, Pines G.

Evol Bioinform Online. 2016 Apr 20;11(Suppl 2):53-5. doi: 10.4137/EBO.S39729. eCollection 2015. No abstract available.

18.

Codon compression algorithms for saturation mutagenesis.

Pines G, Pines A, Garst AD, Zeitoun RI, Lynch SA, Gill RT.

ACS Synth Biol. 2015 May 15;4(5):604-14. doi: 10.1021/sb500282v. Epub 2014 Oct 30.

PMID:
25303315
19.

Extraesophageal malignancies among patients with Barrett esophagus.

Pines G, Dickman R, Niv Y, Kashtan H, Birkenfeld S.

J Clin Gastroenterol. 2014 Jan;48(1):e8-e11. doi: 10.1097/MCG.0b013e31828bf26f.

PMID:
23507770
20.

The ERBB network: at last, cancer therapy meets systems biology.

Yarden Y, Pines G.

Nat Rev Cancer. 2012 Jul 12;12(8):553-63. doi: 10.1038/nrc3309. Review.

PMID:
22785351
21.

EGR1 and the ERK-ERF axis drive mammary cell migration in response to EGF.

Tarcic G, Avraham R, Pines G, Amit I, Shay T, Lu Y, Zwang Y, Katz M, Ben-Chetrit N, Jacob-Hirsch J, Virgilio L, Rechavi G, Mavrothalassitis G, Mills GB, Domany E, Yarden Y.

FASEB J. 2012 Apr;26(4):1582-92. doi: 10.1096/fj.11-194654. Epub 2011 Dec 23.

22.

Deubiquitination of EGFR by Cezanne-1 contributes to cancer progression.

Pareja F, Ferraro DA, Rubin C, Cohen-Dvashi H, Zhang F, Aulmann S, Ben-Chetrit N, Pines G, Navon R, Crosetto N, Köstler W, Carvalho S, Lavi S, Schmitt F, Dikic I, Yakhini Z, Sinn P, Mills GB, Yarden Y.

Oncogene. 2012 Oct 25;31(43):4599-608. doi: 10.1038/onc.2011.587. Epub 2011 Dec 19.

23.

One hundred transhiatal esophagectomies: a single-institution experience.

Pines G, Klein Y, Melzer E, Idelevich E, Buyeviz V, Machlenkin S, Kashtan H.

Isr Med Assoc J. 2011 Jul;13(7):428-33.

24.

Disease-related mortality within the first year after subtotal esophagectomy for cancer.

Pines G, Klein Y, Buyeviz V, Idelevich E, Kashtan H.

Ann Surg Oncol. 2011 Apr;18(4):1139-44. doi: 10.1245/s10434-010-1386-4. Epub 2010 Nov 3.

PMID:
21046267
25.

Kinase-mediated quasi-dimers of EGFR.

Bublil EM, Pines G, Patel G, Fruhwirth G, Ng T, Yarden Y.

FASEB J. 2010 Dec;24(12):4744-55. doi: 10.1096/fj.10-166199. Epub 2010 Aug 3.

26.

EGFRvIV: a previously uncharacterized oncogenic mutant reveals a kinase autoinhibitory mechanism.

Pines G, Huang PH, Zwang Y, White FM, Yarden Y.

Oncogene. 2010 Oct 28;29(43):5850-60. doi: 10.1038/onc.2010.313. Epub 2010 Aug 2.

27.

Oncogenic mutant forms of EGFR: lessons in signal transduction and targets for cancer therapy.

Pines G, Köstler WJ, Yarden Y.

FEBS Lett. 2010 Jun 18;584(12):2699-706. doi: 10.1016/j.febslet.2010.04.019. Epub 2010 Apr 11. Review.

28.

The use of circular stapler for cervical esophagogastric anastomosis after esophagectomy: surgical technique and early postoperative outcome.

Pines G, Buyeviz V, Machlenkin S, Klein Y, Laor A, Kashtan H.

Dis Esophagus. 2009;22(3):274-8.

PMID:
19431220
29.

High cytomegalovirus IgG avidity is a reliable indicator of past infection in patients with positive IgM detected during the first trimester of pregnancy.

Kanengisser-Pines B, Hazan Y, Pines G, Appelman Z.

J Perinat Med. 2009;37(1):15-8. doi: 10.1515/JPM.2009.012.

PMID:
18673093
30.

Small bowel obstruction due to tubo-ovarian abscess.

Pines G, Klein Y, Ben-Arie A, Machlenkin S, Kashtan H.

Isr Med Assoc J. 2008 Jun;10(6):481-2. No abstract available.

31.

Defective ubiquitinylation of EGFR mutants of lung cancer confers prolonged signaling.

Shtiegman K, Kochupurakkal BS, Zwang Y, Pines G, Starr A, Vexler A, Citri A, Katz M, Lavi S, Ben-Basat Y, Benjamin S, Corso S, Gan J, Yosef RB, Giordano S, Yarden Y.

Oncogene. 2007 Oct 25;26(49):6968-78. Epub 2007 May 7.

PMID:
17486068
32.

Effect of enzyme replacement therapy on gammopathies in Gaucher disease.

Brautbar A, Elstein D, Pines G, Abrahamov A, Zimran A.

Blood Cells Mol Dis. 2004 Jan-Feb;32(1):214-7.

PMID:
14757437
33.

Viral infections and phenotypic heterogeneity in Gaucher disease.

Pines G, Morag A, Elstein D, Abrahamov A, Zimran A.

Blood Cells Mol Dis. 2001 Mar-Apr;27(2):358-61.

PMID:
11259156
34.
35.
36.

Structure and function of the sodium and potassium-coupled glutamate transporter from rat brain.

Kanner BI, Danbolt N, Pines G, Koepsell H, Seeberg E, Mathisen JS.

Biochem Soc Trans. 1993 Feb;21(1):59-61. Review. No abstract available.

PMID:
8095473
37.

Cloning and expression of a rat brain L-glutamate transporter.

Pines G, Danbolt NC, Bjørås M, Zhang Y, Bendahan A, Eide L, Koepsell H, Storm-Mathisen J, Seeberg E, Kanner BI.

Nature. 1992 Dec 3;360(6403):464-7. Erratum in: Nature 1992 Dec 24-31;360(6406):768.

PMID:
1448170
38.
39.
40.

Enzyme immobilization via monoclonal antibodies I. Preparation of a highly active immobilized carboxypeptidase A.

Solomon B, Koppel R, Pines G, Katchalski-Katzir E.

Biotechnol Bioeng. 1986 Aug;28(8):1213-21.

PMID:
18555448
41.

Interaction of carboxypeptidase A with monoclonal antibodies.

Solomon B, Moav N, Pines G, Katchalski-Katzir E.

Mol Immunol. 1984 Jan;21(1):1-11.

PMID:
6200767

Supplemental Content

Support Center